Table 2. CABG Genomics validation study: Nineteen validated SNPs associated with ventricular dysfunction after primary coronary artery bypass grafting with cardiopulmonary bypass.* .
SNP | Chromosome, Location NCBI hg36 | Gene | GWAS or Additional SNP | Minor Allele/Major Allele | MAF VnD Cases (n = 71)/Controls (n = 715) | Best Genetic Model in GWAS† | Unadjusted Odds Ratio | Univariate Asymptotic P value | Multivariable Adjusted Odds Ratio | Multivariate Asymptotic P value |
rs1287820 | Chr 1, 180,855,954 | GWAS | G/C | 0.32/0.20 | Additive | 2.00 | 0.0004 | 2.26 | 0.0002 | |
rs17691914 | Chr 3, 34,937,807 | GWAS | G/A | 0.19/0.08 | Additive | 2.74 | 2.7×10−5 | 2.96 | 6.0×10−5 | |
rs9835451 | Chr 3, 34,946,568 | GWAS | G/A | 0.22/0.11 | Additive | 2.14 | 0.0005 | 2.29 | 0.001 | |
rs17358517 | Chr 3, 59,660,772 | GWAS | T/C | 0.38/0.23 | Additive | 2.07 | 9.6×10−5 | 2.14 | 0.0002 | |
rs17061085 | Chr 3, 59,666,765 | Additional | A/G | 0.26/0.13 | Additive | 2.04 | 0.0001 | 2.08 | 0.0004 | |
rs9837024 | Chr 3, 78,534,327 | GWAS | G/A | 0.36/0.22 | Additive | 2.09 | 0.0002 | 1.95 | 0.002 | |
rs4242051 | Chr 5, 54,234,532 | GWAS | T/C | 0.40/0.28 | Recessive | 3.30 | 0.0002 | 2.73 | 0.005 | |
rs6459959 | Chr 7, 155,390,912 | GWAS | C/G | 0.51/0.36 | Additive | 1.88 | 0.0004 | 1.78 | 0.002 | |
rs6459961 | Chr 7, 155,391,016 | GWAS | C/A | 0.51/0.36 | Additive | 1.88 | 0.0004 | 1.78 | 0.002 | |
rs10104640 | Chr 8, 40,762,563 | ZMAT4 | GWAS | A/C | 0.38/0.27 | Recessive | 3.43 | 6.7×10−5 | 3.51 | 0.0003 |
rs10500830 | Chr 11, 16,441,827 | SOX6 | GWAS | A/G | 0.28/0.19 | Recessive | 5.37′ | 3.6×10−5 | 6.18 | 0.0001 |
rs12279572 | Chr 11, 117,458,170 | TMPRSS4 | GWAS | G/A | 0.36/0.29 | Recessive | 3.61 | 3.5×10−5 | 3.61 | 0.0002 |
rs7975290 | Chr 12, 26,505,185 | ITPR2 | GWAS | G/A | 0.14/0.05 | Additive | 2.91 | 8.4×10−5 | 3.53 | 4.5×10−5 |
rs10773689 | Chr 12, 128,686,079 | TMEM132D | GWAS | A/C | 0.24/0.39 | Additive | 0.50 | 0.0007 | 0.47 | 0.0005 |
rs10519861 | Chr 15, 31,773,350 | RYR3 | GWAS | T/G | 0.56/0.40 | Additive | 2.00 | 0.0001 | 2.18 | 0.0001 |
rs8027394 | Chr 15, 76,404,968 | GWAS | T/C | 0.48/0.30 | Additive | 2.06 | 4.2×10−5 | 2.12 | 0.0002 | |
rs12593362 | Chr 15, 76,421,786 | Additional | T/G | 0.47/0.31 | Additive | 1.99 | 0.0001 | 2.10 | 0.0002 | |
rs8058644 | Chr 16, 48,454,181 | GWAS | T/C | 0.18/0.07 | Additive | 2.61 | 6.8×10−5 | 2.86 | 8.7×10−5 | |
rs16974035 | Chr 18, 10,269,356 | GWAS | G/A | 0.49/0.34 | Additive | 1.86 | 0.0005 | 1.96 | 0.0005 |
Chr = chromosome; GWAS = genome-wide association study; MAF = minor allele frequency; SNP = single nucleotide polymorphism; VnD = ventricular dysfunction.
*19 SNPs with univariate asymptotic and point-wise permuted P values≤0.0005 (allelic, additive, or recessive models) were selected from the CABG Genomics validation study's 63 assessed SNPs (Table S2) for further assessment.
†When GWAS data indicated allelic genetic model as the most significant, Table 2 reports additive model results for the validation study to show multivariate adjusted results.